Recovering from Controlled Substance Theft with C2 Keep

Although it may seem unlikely, controlled substance theft in pharmacies is very real and can have devastating operational, financial, and regulatory consequences. Pharmacies are frequently targeted due to the high demand for controlled substances, especially Schedule II medications. The ongoing opioid crisis has created dependency among millions of Americans, fueling a lucrative illegal market for diversion and resale.

In 2023 alone, the Drug Enforcement Administration received nearly 900 burglary reports involving the theft of controlled substances. These incidents impact far more than inventory. They trigger audits, DEA reporting requirements, and long recovery timelines for pharmacy teams that are already stretched thin.

While you cannot always prevent a diversion attempt, you can take meaningful steps to minimize the damage and accelerate recovery. Pharmacies that use C2 Keep have a distinct advantage when responding to controlled substance theft. In this blog, we will break down why theft happens, how pharmacies are required to respond, where traditional compliance methods fall short, and how C2 Keep simplifies recovery after controlled substance theft.

Controlled substances are valuable not only to patients who legitimately need them, but also to individuals seeking to misuse or resell them. This demand has led to increasingly sophisticated diversion strategies. In many cases, the people involved are not who pharmacies expect.

When most people think of controlled substance theft, they picture an overnight burglary in which individuals break into a pharmacy and steal inventory. In many cases, this is accurate. External theft often happens all at once and may involve forced entry, physical damage to the building, and the loss of large quantities of controlled substances.

However, external diversion is not always immediate or obvious. In some situations, it can occur gradually over weeks, months, or even years. From a pharmacist’s perspective, this may include patients who exploit prescribing gaps, engage in prescription fraud, or otherwise divert controlled substances in more subtle ways.

Regardless of how it presents, external theft and diversion are highly disruptive and typically trigger immediate regulatory action. Any instance of controlled substance theft or diversion that involves individuals outside of the pharmacy’s staff or internal operations is classified as external diversion.

Internal theft occurs when a member of the pharmacy staff diverts controlled substances and is often subtle and ongoing before being detected. Because employees have access to inventory, records, and workflows, internal theft may involve small quantities taken over time. In some cases, records are altered to make counts appear accurate, making controlled substance theft much harder to uncover without strong inventory controls.

In some cases, controlled substance theft involves both internal and external actors. The DEA has published cases where pharmacy staff collaborated with outside individuals to divert medication. In one such case, a pharmacist and a patient diverted more than 1,500 pills of alprazolam and oxycodone. The pharmacist used his position to facilitate the theft and received compensation for each pill sold illegally.

The outcome was severe. The pharmacist was sentenced to federal prison, and the pharmacy faced over $200,000 in civil penalties for failing to maintain accurate controlled substance records. This highlights how recordkeeping failures can amplify the consequences of controlled substance theft.

When controlled substance theft occurs, pharmacies are required under the Controlled Substances Act to act quickly. This includes notifying the local DEA Division Field Office in writing and submitting a DEA Form 106 detailing the theft or loss.

For many pharmacies, the only tools available during this process are paper logbooks, Excel spreadsheets, or their pharmacy management system. These tools are often used to reconstruct inventory history and calculate losses. Unfortunately, they are rarely designed to support fast, accurate recovery after controlled substance theft.

The two most common issues pharmacies face when responding to controlled substance theft are inaccurate data and inefficiency.

Manual processes like paper logbooks and Excel spreadsheets are vulnerable to errors. Pages can be damaged or destroyed, files can be misplaced, and data entry mistakes are common in busy pharmacy environments.

Incorrect calculations, illegible handwriting, and missed entries can create serious problems when pharmacies attempt to identify what was stolen. During controlled substance theft investigations, even small discrepancies can raise red flags with regulators.

Even when data is accurate, compiling it can be overwhelming. Audits that rely on a pharmacy management system plus manual logs often require teams to sift through hundreds or thousands of transactions.

Reconciling discrepancies, calculating drug costs, and preparing documentation while under DEA scrutiny is time-consuming and stressful. Completing a DEA Form 106 on top of these tasks adds another layer of burden during an already difficult situation.

Recovering from controlled substance theft is never easy, but C2 Keep makes the process far more manageable. With perpetual inventory tracking, detailed reporting, and centralized documentation, C2 Keep gives pharmacies the tools they need to respond confidently and compliantly.

Here is how C2 Keep supports pharmacies after controlled substance theft:

For pharmacies using C2 Keep, one best practice is to confirm pending transactions as quickly as possible. Allowing transactions to remain pending can create discrepancies during audits.

In a recent controlled substance theft case involving a C2 Keep customer, several transactions had already been dispensed in real time but were still pending in the system. When the pharmacy ran theft reports, inventory counts appeared incorrect.

Maintaining timely transaction confirmation ensures C2 Keep reflects true on-hand inventory, which is critical when responding to controlled substance theft.

Controlled substance theft is a serious and ongoing risk in the pharmacy environment. While prevention is important, having a clear plan for responding to theft is just as critical.

C2 Keep helps pharmacies maintain accurate, secure controlled substance records and simplifies recovery when theft occurs. By reducing audit time, improving accuracy, and supporting DEA compliance, C2 Keep gives pharmacies confidence during one of their most challenging situations.

To learn more about how C2 Keep can support your pharmacy after controlled substance theft, schedule a demo with Founder and CEO Roland Achenjang today.